VYNE - VYNE Therapeutics: Terrible Depreciation Of Shareholder Value June, 30 2021 01:18 PM VYNE Therapeutics Inc Com VYNE stock has depreciated by 65% in the last 3 months. There are no overwhelmingly critical factors behind this. The market, and smart money, just seem to dislike the stock. For further details see: VYNE Therapeutics: Terrible Depreciation Of Shareholder Value